SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001185185-20-000507
Filing Date
2020-04-21
Accepted
2020-04-21 14:57:57
Documents
1
Group Members
MV AMANTH, LLCROBERT S. HERSCH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A ozrey20200421_sc13da.htm SC 13D/A 105146
  Complete submission text file 0001185185-20-000507.txt   106916
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Subject) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81795 | Film No.: 20804954
SIC: 2834 Pharmaceutical Preparations

Mailing Address 515 CONGRESS AVE STE 1400 AUSTIN TX 78701
Business Address 515 CONGRESS AVE STE 1400 AUSTIN TX 78701 5128180233
Oz Rey LLC (Filed by) CIK: 0001794761 (see all company filings)

IRS No.: 810878951 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A